CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021

SEATTLE, March 12, 2021 /PRNewswire/ — CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its fourth quarter and full year 2020 financial results on Wednesday, March 17, 2021, after the close of the U.S. financial markets. Following the…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.